Heery Christopher's Form 4 filing
Arcellx, Inc. (ACLX) · filed Apr 20, 2023
- Accession no.
- 0001209191-23-024979
- Filed
- Apr 20, 2023
- Trade date
- Apr 18-19, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $757.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Heery ChristopherCIK 0001789632 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 18, 2023 | Common Stock | MOption exerciseAcquired | +3,000 | $6.28 | +$18,840 | 18,589 | Direct | |
| Apr 18, 2023 | Common Stock | MOption exerciseAcquired | +2,400 | $15.00 | +$36,000 | 20,989 | Direct | |
| Apr 18, 2023 | Common Stock | SSaleDisposed | −6,000 | $35.00 | −$210,000 | 14,989 | Direct | |
| Apr 19, 2023 | Common Stock | MOption exerciseAcquired | +2,600 | $6.28 | +$16,328 | 17,589 | Direct | |
| Apr 19, 2023 | Common Stock | MOption exerciseAcquired | +9,745 | $15.00 | +$146,175 | 27,334 | Direct | |
| Apr 19, 2023 | Common Stock | SSaleDisposed | −15,642 | $35.01F2 | −$547,626.42 | 11,692 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 18, 2023 | Common Stock | MOption exerciseDisposed | −3,000 | $0.00 | $0 | 253,223 | Direct | |
| Apr 18, 2023 | Common Stock | MOption exerciseDisposed | −2,400 | $0.00 | $0 | 243,950 | Direct | |
| Apr 19, 2023 | Common Stock | MOption exerciseDisposed | −2,600 | $0.00 | $0 | 250,623 | Direct | |
| Apr 19, 2023 | Common Stock | MOption exerciseDisposed | −9,745 | $0.00 | $0 | 234,205 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 15,642 shares sold in the price range of $35.00 to $35.17 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.